Tokyo, Japan

Tomohiro Narumi

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tomohiro Narumi: Innovator in Alginic Acid Technologies

Introduction

Tomohiro Narumi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of alginic acid technologies, holding a total of 4 patents. His work focuses on innovative methods and structures that enhance the applications of alginic acid in various industries.

Latest Patents

Narumi's latest patents include a novel crosslinked alginic acid structure. This invention involves performing a crosslinking reaction using alginic acid derivatives, resulting in a unique crosslinked alginic acid and its structures. Another notable patent is the polymer-coated crosslinked alginate gel fiber. This invention addresses the demand for additional methods to produce antibodies. It features a core layer containing a crosslinked alginate gel, which is coated with a cationic polymer, facilitating the production of antibodies and bioactive substances.

Career Highlights

Narumi is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to innovate and develop new technologies. His work has been instrumental in advancing the applications of alginic acid in the pharmaceutical and biotechnology sectors.

Collaborations

Throughout his career, Narumi has collaborated with notable colleagues, including Shoji Furusako and Tsutomu Satoh. These collaborations have further enriched his research and development efforts.

Conclusion

Tomohiro Narumi is a key figure in the field of alginic acid innovations, with a focus on developing novel structures and methods that have significant implications for the pharmaceutical industry. His contributions continue to shape the future of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…